Holen Sie sich die Stockscreener-App
6.205
1.55%
0.095
Schlusskurs vom Vortag:
$6.11
Offen:
$6.11
24-Stunden-Volumen:
206.61K
Relative Volume:
0.80
Marktkapitalisierung:
$168.98M
Einnahmen:
$348.67M
Nettoeinkommen (Verlust:
$-22.75M
KGV:
-7.2395
EPS:
-0.8571
Netto-Cashflow:
$-21.60M
1W Leistung:
-1.82%
1M Leistung:
+1.72%
6M Leistung:
-24.05%
1J Leistung:
-12.97%
1-Tages-Spanne:
$5.855
$6.26
1-Wochen-Bereich:
$5.855
$6.66
52-Wochen-Spanne:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.205 | 166.39M | 348.67M | -22.75M | -21.60M | -0.8571 |
ABT
Abbott Laboratories
|
102.47 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.72 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.40 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Inogen reports inducement grants - Medical Buyer
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference - The Joplin Globe
Inogen CEO to speak April 14 at Needham healthcare event - Stock Titan
Inogen appoints new CFO - MSN
Inogen (INGN) Announces Key Leadership Changes to Propel Growth - gurufocus.com
Inogen (INGN) Affirms Q1 Revenue Projections - gurufocus.com
Inogen (INGN) Reaffirms FY26 Revenue Outlook Amid Market Adjustm - gurufocus.com
Inogen Reports Inducement Grants - National Today
Inogen (NASDAQ: INGN) appoints new CFO and growth-focused commercial leaders - Stock Titan
Inogen names new CFO, CMO in leadership reshuffle By Investing.com - Investing.com India
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth - FinancialContent
Institution Moves: Is Inogen Inc impacted by rising rates2026 Rallies & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Inogen Inc Stock: Portable Oxygen Leader Faces Profitability Hurdles Amid Aging Population Demand - AD HOC NEWS
S P Trends: Is Inogen Inc a turnaround storyWeekly Trade Analysis & Breakout Confirmation Trade Signals - baoquankhu1.vn
Inogen (NASDAQ:INGN) Shares Cross Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Inogen (INGN) up 6.8% since last earnings report: Can it continue? - MSN
Vanguard disaggregates holdings; INGN shows 0 shares (INGN) - Stock Titan
Inogen (INGN) Up 6.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Aug Breakouts: Does Inogen Inc have pricing power2026 Momentum & AI Optimized Trade Strategies - baoquankhu1.vn
Dow Update: Is Inogen Inc gaining market share2026 Summary & Low Risk Entry Point Guides - baoquankhu1.vn
If You Invested $1,000 in Inogen Inc (INGN) - Stock Titan
Market Fear: How sensitive is Inogen Inc to inflationMarket Performance Recap & High Conviction Trade Alerts - baoquankhu1.vn
Inogen CEO: Turnaround Driving Positive EBITDA, $3B TAM Expansion Beyond Portable Oxygen - Yahoo Finance
Panic Selling: Is Inogen Inc impacted by rising ratesForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Inogen Inc Stock (ISIN: US45780L1044) Faces Headwinds Amid Portable Oxygen Slowdown - AD HOC NEWS
Aug Outlook: Is Inogen Inc likely to announce a buybackWeekly Profit Recap & Verified Chart Pattern Trade Signals - baoquankhu1.vn
CSM Advisors LLC Buys Shares of 364,100 Inogen, Inc $INGN - MarketBeat
Inogen, Inc $INGN Shares Sold by Divisadero Street Capital Management LP - MarketBeat
What Is Behind Rising Interest In Inogen Respiratory Care Technology? - Kalkine Media
Short Interest in Inogen, Inc (NASDAQ:INGN) Expands By 24.2% - MarketBeat
Earnings Update: Is Inogen Inc forming bullish engulfing patterns2026 Growth vs Value & Technical Confirmation Alerts - baoquankhu1.vn
Inogen Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Inogen (NASDAQ:INGN) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Here's why you should add Inogen stock to your portfolio now - MSN
Exit Recap: What are the risks of holding Inogen IncJuly 2025 Final Week & AI Enhanced Trading Signals - baoquankhu1.vn
Earnings Beat: Is Inogen Inc a turnaround storyJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum - The AI Journal
Comparing Neuronetics (NASDAQ:STIM) & Inogen (NASDAQ:INGN) - Defense World
Inogen, Inc (NASDAQ:INGN) Short Interest Update - MarketBeat
Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds - TipRanks
[Form 4] Inogen Inc Insider Trading Activity - Stock Titan
Inogen (NASDAQ: INGN) EVP reports RSU grant, vesting and tax disposals - Stock Titan
Inogen (INGN) CCO reports RSU vesting and 20,000-unit grant - Stock Titan
Inogen (INGN) EVP Kevin P. Smith reports RSU grants and tax share withholding - Stock Titan
Inogen (NASDAQ: INGN) CFO logs RSU vesting, share tax withholdings - Stock Titan
Inogen (INGN) CEO receives 90,000 RSU grant and reports tax share withholdings - Stock Titan
INGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revenue Check: Whats the beta of Inogen Inc stock2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
What’s the beta of Inogen Inc. stock2025 Price Momentum & Daily Price Action Insights - mfd.ru
Inogen (NASDAQ: INGN) outlines 2025 revenue mix and respiratory growth strategy - Stock Titan
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Inogen Inc-Aktie (INGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off |
Mar 01 '26 |
Option Exercise |
0.00 |
25,017 |
0 |
33,699 |
| Ramade Gregoire | Chief Commercial Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
13,005 |
0 |
50,251 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Mar 01 '26 |
Option Exercise |
0.00 |
14,005 |
0 |
28,283 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
42,007 |
0 |
100,949 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '26 |
Option Exercise |
0.00 |
58,346 |
0 |
147,973 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '25 |
Option Exercise |
0.00 |
31,566 |
0 |
50,189 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '25 |
Option Exercise |
0.00 |
28,334 |
0 |
100,108 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Sep 01 '25 |
Option Exercise |
0.00 |
18,135 |
0 |
20,821 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):